The numbers
Oklo, a company specializing in small modular nuclear reactors (SMRs), reported earnings of -$0.27 per share for the fourth quarter of 2025, falling short of analysts’ expectations by $0.10. The company also disclosed a net loss of $105.7 million for the entire year, a significant increase from the $73.6 million loss reported in 2024.
On the day of the earnings report, shares of Oklo traded at $60.53, reflecting a modest increase of 1.4%. However, the stock’s performance has raised concerns among investors, particularly as Oklo has yet to generate any revenue from power or radioisotope sales.
In a notable trend, Oklo insiders have engaged in trading $OKLO stock 177 times over the past six months, with no purchases and all trades being sales. This pattern may indicate a lack of confidence among insiders regarding the company’s immediate financial prospects.
Despite these challenges, Oklo has received critical approvals from the US Department of Energy (DOE) and the Nuclear Regulatory Commission (NRC) for its reactor project in Idaho. This regulatory progress comes amid a broader governmental push to expand nuclear power, coupled with rising investments from major technology companies like Meta to support data centers and artificial intelligence initiatives.
Jacob DeWitte, a representative from Oklo, noted, “Demand for critical isotopes is rising,” highlighting the potential market for the company’s future products. However, he also remarked that “shares remain a bet on future execution rather than any current revenue stream,” underscoring the uncertainty surrounding Oklo’s financial trajectory.
At the end of 2025, Oklo reported liquidity of approximately $1.41 billion, which may provide some cushion as the company navigates its financial challenges. Management has projected that investing cash outflows for 2026 will range between $350 million and $450 million, indicating a continued commitment to development despite the current losses.
However, details remain unconfirmed regarding the construction of any reactors, as no binding power purchase agreements for electricity or heat have been established. Additionally, Oklo’s plans are contingent on access to high-assay low-enriched uranium (HALEU), a resource that is both scarce and expensive, further complicating their operational outlook.
As observers watch closely, the future of Oklo stock will depend on the company’s ability to execute its plans effectively and secure the necessary resources to move forward in the competitive nuclear energy landscape.
